A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer [clinicaltrials:NCT01654458]

Bio2RDF uri

A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer [clinicaltrials:NCT01654458]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT01654458

Bio2RDF identifier

NCT01654458

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT01654458

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT01654458

anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]

520

http://www.w3.org/2001/XMLSchema#integer

arm group [clinicaltrials_vocabulary:arm-group]

NCT01654458 arm group 3db264c1cdd5f2b28da6fb2769419cb9 [clinicaltrials_resource:NCT01654458/arm-group/3db264c1cdd5f2b28da6fb2769419cb9]

NCT01654458 arm group 57737b0ddd7ea481ddab971899dcb0fb [clinicaltrials_resource:NCT01654458/arm-group/57737b0ddd7ea481ddab971899dcb0fb]

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:95decef22cd11d2a6c81a50b3679c18c

brief summary [clinicaltrials_vocabulary:brief-summary]

There is a high prevale ...... he side effects of treatment.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

A Randomized Controlled Trial ...... ress Due to Gynecologic Cancer

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Psychosexual distress, as measured by the Revised Female Sexual Distress Scale (FSDS-R). 9 months [clinicaltrials_resource:f87000d06f567f3f6d0970afe92c7702]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Psychosexual distress, as measured by the Revised Female Sexual Distress Scale (FSDS-R). 9 months [clinicaltrials_resource:397b09ed48d6b0fdcdd8464efbdbb79f]

Psychosexual distress, as measured by the Revised Female Sexual Distress Scale (FSDS-R). 9 months [clinicaltrials_resource:664062fdf868e5de352a9213e2ffd910]

Psychosexual distress, as measured by the Revised Female Sexual Distress Scale (FSDS-R). 9 months [clinicaltrials_resource:8a482a634043f95b3bf8fab1bd539c73]

Psychosexual distress, as measured by the Revised Female Sexual Distress Scale (FSDS-R). 9 months [clinicaltrials_resource:a2c02798accf7433c48ad9404098a605]

Psychosexual distress, as measured by the Revised Female Sexual Distress Scale (FSDS-R). 9 months [clinicaltrials_resource:f11c572c090d6b9ea2a1645f839af1c9]

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT01654458 [clinicaltrials_resource:0ba37d226c048b0e3d6b9d6a55f05e59]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2012-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

GyneGals Support Group [clinicaltrials_resource:b37cb9f85281c2c74e45ab28a45ea497]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

Endometrial Neoplasms

http://www.w3.org/2001/XMLSchema#string

Fallopian Tube Neoplasms

http://www.w3.org/2001/XMLSchema#string

Genital Neoplasms, Female

http://www.w3.org/2001/XMLSchema#string

Ovarian Neoplasms

http://www.w3.org/2001/XMLSchema#string

Psychotherapy, Group

http://www.w3.org/2001/XMLSchema#string

Sexual Dysfunctions, Psychological

http://www.w3.org/2001/XMLSchema#string

Urogenital Neoplasms

http://www.w3.org/2001/XMLSchema#string

Uterine Cervical Neoplasms

http://www.w3.org/2001/XMLSchema#string

Uterine Neoplasms

http://www.w3.org/2001/XMLSchema#string

Vaginal Neoplasms

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2015-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Women's College Hospital [clinicaltrials_resource:ebdbabccda6e15c3878d4eb67a0655c0]

location [clinicaltrials_vocabulary:location]

Memorial Sloan Kettering Cancer Center [clinicaltrials_resource:943ffc712b96f2648d27fc590fe1a985]

nct id [clinicaltrials_vocabulary:nct-id]

NCT01654458

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

A Randomized Controlled Trial ...... ress Due to Gynecologic Cancer

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

OVA-120243

http://www.w3.org/2001/XMLSchema#string

overall contact [clinicaltrials_vocabulary:overall-contact]

Catherine C. Classen, PhD [clinicaltrials_resource:0d681a744f6942194e43b2dee68d26d7]

overall official [clinicaltrials_vocabulary:overall-official]

Catherine C. Classen, PhD [clinicaltrials_resource:fd1289365ebadf3b1416f0ee69c86b4f]

overall status [clinicaltrials_vocabulary:overall-status]

Recruiting [clinicaltrials_resource:5231dee7156b84b0d1854de1a18dd169]

oversight [clinicaltrials_vocabulary:oversight]

Canada: Canadian Institutes of Health Research [clinicaltrials_resource:7169d63fda04c7f8fb601d9a86eda5da]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

reference [clinicaltrials_vocabulary:reference]

21594587 [pubmed:21594587]

22374732 [pubmed:22374732]

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

secondary id [clinicaltrials_vocabulary:secondary-id]

1,009,695

http://www.w3.org/2001/XMLSchema#integer

source [clinicaltrials_vocabulary:source]

Women's College Hospital [clinicaltrials_resource:ebdbabccda6e15c3878d4eb67a0655c0]

start date [clinicaltrials_vocabulary:start-date]

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT01654458 study design [clinicaltrials_resource:a07c512d7f629bd6bc09d7506866a9ef]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT01654458

verification date [clinicaltrials_vocabulary:verification-date]

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT01654458

http://www.w3.org/2001/XMLSchema#string

title

A Randomized Controlled Trial ...... ress Due to Gynecologic Cancer

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

A Randomized Controlled Trial ...... r [clinicaltrials:NCT01654458]

@en